25.36
Transplantation de tissus
La transplantation de tissus est une procédure médicale importante qui implique le transfert de cellules, de tissus ou d'organes d'un donneur à un rec…
La transplantation de tissus est une procédure médicale complexe mais vitale qui consiste à transférer des cellules, des tissus ou des organes d’un donneur à un receveur pour restaurer les fonctions perdues.
Cette procédure repose fortement sur la présence de molécules du CMH ou du HLA, qui sont essentielles pour distinguer les cellules du « soi » et du « non-soi ».
Ces molécules du CMH sont uniques à chaque individu en raison de la présence de plusieurs protéines du CMH sur les cellules, du polymorphisme du gène du CMH et de plusieurs allèles pour chaque locus du CMH.
Ainsi, trouver un donneur compatible dont les molécules du CMH correspondent à celles du receveur est un défi majeur. Une greffe réussie nécessite une compatibilité entre au moins 3 à 4 molécules du CMH.
Une discordance entre les molécules du CMH d’un organe donneur et du receveur peut déclencher une réponse cytotoxique des lymphocytes T, conduisant souvent au rejet de la greffe.
Malgré de nombreux défis, le potentiel thérapeutique de la transplantation de tissus est considérable. Par exemple, l’insuffisance hépatique en phase terminale, l’insuffisance cardiaque ou des maladies telles que l’immunodéficience combinée sévère sont traitées avec succès par la transplantation d’organes.
View the full transcript and gain access to JoVE Core videos
Q1: Why are MHC molecules important in tissue transplantation?
MHC molecules are essential for distinguishing 'self' and 'non-self' cells. The immune system recognizes foreign MHC molecules on transplanted tissue and can trigger a cytotoxic T cells mediated immune response, leading to transplant rejection. Each individual has a unique set of MHC molecules due to gene polymorphism and multiple alleles, making donor-recipient matching critical for transplant success.
Q2: What does MHC polymorphism mean in the context of transplantation?
MHC polymorphism refers to the presence of multiple alleles for each MHC locus, creating vast genetic variation among individuals. Combined with polygeny—the presence of multiple MHC proteins on cells—this polymorphism makes each person's MHC profile unique. This genetic diversity is why finding a suitable donor match is extremely challenging and often requires searching worldwide databases.
Q3: How many MHC molecules must match for a successful transplant?
A successful transplant typically requires a match between at least 3–4 MHC molecules between donor and recipient. More matches are associated with increased success rates and reduced risk of rejection. However, achieving even this minimum level of matching is difficult due to the extensive polymorphisms in MHC molecules across the population.
Q4: What conditions can be treated with tissue transplantation?
Tissue transplantation treats end-stage organ failure including heart, liver, and kidney failure. Bone marrow transplants successfully address Severe Combined Immunodeficiency and leukemia. However, bone marrow transplants can cause graft-versus-host disease, where transplanted cells attack recipient tissues, leading to multiple organ damage and requiring careful management.
Q5: What is graft-versus-host disease in bone marrow transplants?
Graft-versus-host disease occurs when transplanted bone marrow cells attack the recipient's own tissues, causing damage to multiple organs. This complication represents a significant challenge in bone marrow transplantation. While efforts continue to moderate its effects, it remains an important consideration when evaluating the risks and benefits of bone marrow transplants for patients.
Q6: Why is finding a donor match so difficult in tissue transplantation?
Finding a donor match is challenging because MHC molecules exhibit both polygeny and polymorphism, creating unique profiles for each individual. The extensive genetic variation in MHC loci means compatible donors are rare. Searches often extend to worldwide databases to locate unrelated donors whose MHC molecules sufficiently match the recipient's profile.
Q7: How does the immune system respond to mismatched MHC molecules?
When donor and recipient MHC molecules mismatch, the immune system recognizes the transplanted tissue as foreign. This triggers an adaptive immune response, particularly a cytotoxic T-cell response that attacks and destroys the transplanted tissue. This immune rejection is the primary barrier to successful transplantation and is why MHC matching is so critical.